In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Novartis teams up with Epistem to develop stem cell therapies

Executive Summary

Epistem PLC (using epithelial stem cells to create treatments for various diseases) will combine its stem cell expertise and drug discovery program with Novartis' bioinformatics and disease pathways knowledge to discover and develop new therapeutics across various epithelial conditions reportedly including cancer and gastrointestinal disorders.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies